To elucidate which major T cell subset is essential for tumor regression, we depleted CD4+ or CD8+ T cells from animals bearing PD-L2 KO pancreatic tumors, which were subsequently treated with doxorubicin (Extended Data Fig. 4b,c). Here, CD4 is linked to neoplasm.